A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Clinical trial NCT07730021 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07730021
Sponsor: Astellas Pharma Global Development, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2026-08-31
Primary completion: 2030-02-28
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.